Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online March 2, 2007
Diabetes Care 30:1125-1130, 2007
DOI: 10.2337/dc06-1602
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dc06-1602v1
30/5/1125    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weinstein, R. L.
Right arrow Articles by McGarraugh, G. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weinstein, R. L.
Right arrow Articles by McGarraugh, G. V.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Emerging Treatments and Technologies
Original Article

Accuracy of the 5-Day FreeStyle Navigator Continuous Glucose Monitoring System

Comparison with frequent laboratory reference measurements

Richard L. Weinstein, MD1, Sherwyn L. Schwartz, MD2, Ronald L. Brazg, MD3, Jolyon R. Bugler, MS4, Thomas A. Peyser, PHD4 and Geoffrey V. McGarraugh, MS4

1 Diablo Clinical Research, Walnut Creek, California
2 Diabetes and Glandular Disease Clinic, San Antonio, Texas
3 Rainier Clinical Research Center, Renton, Washington
4 Abbott Diabetes Care, Alameda, California

Address correspondence and reprint requests to Richard L. Weinstein, MD, Diablo Clinical Research, 2255 Ygnacio Valley Rd., Suite M, Walnut Creek, CA 94598. E-mail: rweinstein{at}diabloclinical.com

OBJECTIVE—The purpose of this study was to compare the accuracy of measurements of glucose in interstitial fluid made with the FreeStyle Navigator Continuous Glucose Monitoring System with Yellow Springs Instrument laboratory reference measurements of venous blood glucose.

RESEARCH DESIGN AND METHODS—Fifty-eight subjects with type 1 diabetes, aged 18–64 years, were enrolled in a multicenter, prospective, single-arm study. Each subject wore two sensors simultaneously, which were calibrated with capillary fingerstick measurements at 10, 12, 24, and 72 h after insertion. Measurements from the FreeStyle Navigator system were collected at 1-min intervals and compared with venous measurements taken once every 15 min for 50 h over the 5-day period of sensor wear in an in-patient clinical research center. Periods of high rates of change of glucose were induced by insulin and glucose challenges.

RESULTS—Comparison of the FreeStyle Navigator measurements with the laboratory reference method (n = 20,362) gave mean and median absolute relative differences (ARDs) of 12.8 and 9.3%, respectively. The percentage in the clinically accurate Clarke error grid A zone was 81.7% and that in the in the benign error B zone was 16.7%. During low rates of change (<±1 mg · dl–1 · min–1), the percentage in the A zone was higher (84.9%) and the mean and median ARDs were lower (11.7 and 8.5%, respectively).

CONCLUSIONS—Measurements with the FreeStyle Navigator system were found to be consistent and accurate compared with venous measurements made using a laboratory reference method over 5 days of sensor wear (82.5% in the A zone on day 1 and 80.9% on day 5).

Abbreviations: ARD, absolute relative difference


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Diabetes CareHome page
S. A. Weinzimer, G. M. Steil, K. L. Swan, J. Dziura, N. Kurtz, and W. V. Tamborlane
Fully Automated Closed-Loop Insulin Delivery Versus Semiautomated Hybrid Control in Pediatric Patients With Type 1 Diabetes Using an Artificial Pancreas
Diabetes Care, May 1, 2008; 31(5): 934 - 939.
[Abstract] [Full Text] [PDF]


Home page
Diabetes Spectr.Home page
J. M. Block and B. Buckingham
Use of Real-Time Continuous Glucose Monitoring Technology in Children and Adolescents
Diabetes Spectr, April 1, 2008; 21(2): 84 - 90.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
Z. T. Bloomgarden
Type 1 Diabetes and Glucose Monitoring
Diabetes Care, November 1, 2007; 30(11): 2965 - 2971.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.